Protalix BioTherapeutics PLX
$ 1.71
2.71%
Quarterly report 2024-Q3
added 11-14-2024
Protalix BioTherapeutics EV/EBITDA Ratio 2011-2024 | PLX
Annual EV/EBITDA Ratio Protalix BioTherapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-2.1 | 45.9 | -9.68 | -4.08 | -2.66 | -2.44 | -3.59 | -9 | -16.3 | -47.7 | -13.2 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
45.9 | -47.7 | -5.9 |